Tudóstér: Takács Barbara publikációi

Szilágyi, A., Takács, B., Szekeres, R., Tarjányi, V., Nagy, D., Priksz, D., Bombicz, M., Kiss, R., Szabó, A., Lehoczki, A., Gesztelyi, R., Juhász, B., Szilvássy, Z., Varga, B.: Effects of voluntary and forced physical exercise on the retinal health of aging Wistar rats.
GeroScience. 46 (5), 4707-4728, 2024.

Takács, B., Szilágyi, A., Priksz, D., Bombicz, M., Szabó, A., Pelles-Taskó, B., Rusznyák, Á., Haimhoffer, Á., Gesztelyi, R., Szilvássy, Z., Juhász, B., Varga, B.: Electroretinographical Analysis of the Effect of BGP-15 in Eyedrops for Compensating Global Ischemia-Reperfusion in the Eyes of Sprague Dawley Rats.
Biomedicines. 12 (3), 1-16, 2024.

Pelles-Taskó, B., Szekeres, R., Takács, B., Szilágyi, A., Ujvárosy, D., Bombicz, M., Priksz, D., Varga, B., Gesztelyi, R., Szabó, Z., Szilvássy, Z., Juhász, B.: From Nature to Treatment: The Impact of Pterostilbene on Mitigating Retinal Ischemia-Reperfusion Damage by Reducing Oxidative Stress, Inflammation, and Apoptosis.
Life (Basel). 14 (9), 1-13, 2024.

Óvári, I., Viczján, G., Erdei, T., Takács, B., Tarjányi, V., Zsuga, J., Szűcs, M., Szilvássy, Z., Juhász, B., Gesztelyi, R.: The influence of the way of regression on the results obtained by the receptorial responsiveness method (RRM), a procedure to estimate a change in the concentration of a pharmacological agonist near the receptor.
Front. Pharmacol. 15 1-18, 2024.

Bernát, B., Erdélyi, R., Fazekas, L., Garami, G., Szekeres, R., Takács, B., Bombicz, M., Varga, B., Sárkány, F., Ráduly, A., Romanescu, D., Papp, Z., Tóth, A., Szilvássy, Z., Juhász, B., Priksz, D.: Drug Candidate BGP-15 Prevents Isoproterenol-Induced Arrhythmias and Alters Heart Rate Variability (HRV) in Telemetry-Implanted Rats.
Pharmaceuticals (Basel). 16 (3), 1-22, 2023.

Blága, Z., Czine, P., Takács, B., Szilágyi, A., Szekeres, R., Wachal, Z., Hegedűs, C., Buchholcz, G., Varga, B., Priksz, D., Bombicz, M., Szabó, A., Kiss, R., Gesztelyi, R., Romanescu, D., Szabó, Z., Szűcs, M., Balogh, P., Szilvássy, Z., Juhász, B.: Examination of Preferences for COVID-19 Vaccines in Hungary Based on Their Properties: Examining the Impact of Pandemic Awareness with a Hybrid Choice Approach.
Int. J. Environ. Res. Public Health. 20 (2), 1-16, 2023.

Szekeres, R., Priksz, D., Kiss, R., Romanescu, D., Bombicz, M., Varga, B., Gesztelyi, R., Szilágyi, A., Takács, B., Tarjányi, V., Pelles-Taskó, B., Forgács, I., Gálné Remenyik, J., Szilvássy, Z., Juhász, B.: Therapeutic Aspects of Prunus cerasus Extract in a Rabbit Model of Atherosclerosis-Associated Diastolic Dysfunction.
Int. J. Mol. Sci. 24 (17), 1-19, 2023.

Kozma, M., Bombicz, M., Varga, B., Priksz, D., Gesztelyi, R., Tarjányi, V., Kiss, R., Szekeres, R., Takács, B., Ménes, Á., Balla, J., Balla, G., Szilvássy, J., Szilvássy, Z., Juhász, B.: Cardioprotective Role of BGP-15 in Ageing Zucker Diabetic Fatty Rat (ZDF) Model: extended Mitochondrial Longevity.
Pharmaceutics. 14 (2), 1-16, 2022.

Wachal, Z., Szilágyi, A., Takács, B., Szabó, A., Priksz, D., Bombicz, M., Szilvássy, J., Juhász, B., Szilvássy, Z., Varga, B.: Corrigendum: Improved survival and retinal function of aging ZDF rats in long-term, uncontrolled diabetes by BGP-15 treatment.
Front. Pharmacol. 13 1-1, 2022.

Viczján, G., Szilágyi, A., Takács, B., Óvári, I., Szekeres, R., Tarjányi, V., Erdei, T., Teleki, V., Zsuga, J., Szilvássy, Z., Juhász, B., Varga, B., Gesztelyi, R.: The effect of a long-term treatment with cannabidiol-rich hemp extract oil on the adenosinergic system of the Zucker Diabetic Fatty (ZDF) rat atrium.
Front. Pharmacol. 13 1-12, 2022.

Szilágyi, A., Takács, B., Szekeres, R., Tarjányi, V., Bombicz, M., Priksz, D., Kovács, A., Juhász, B., Frecska, E., Szilvássy, Z., Varga, B.: Therapeutic Properties of Ayahuasca Components in Ischemia/Reperfusion Injury of the Eye.
Biomedicines. 10 (5), 1-19, 2022.

Viczján, G., Erdei, T., Óvári, I., Lampé, N., Szekeres, R., Bombicz, M., Takács, B., Szilágyi, A., Zsuga, J., Szilvássy, Z., Juhász, B., Gesztelyi, R.: A Body of Circumstantial Evidence for the Irreversible Ectonucleotidase Inhibitory Action of FSCPX, an Agent Known as a Selective Irreversible A1 Adenosine Receptor Antagonist So Far.
Int. J. Mol. Sci. 22 (18), 1-21, 2021.

Wachal, Z., Szilágyi, A., Takács, B., Szabó, A., Priksz, D., Bombicz, M., Szilvássy, J., Juhász, B., Szilvássy, Z., Varga, B.: Improved Survival and Retinal Function of Aging ZDF Rats in Long-Term, Uncontrolled Diabetes by BGP-15 Treatment.
Front. Pharmacol. 12 1-11, 2021.